 "Glenmark Pharma gains on preferential issue plan to Temasek")
Shares of Glenmark Pharmaceuticals were trading higher by 4% at Rs 898 on the National Stock Exchange (NSE), in otherwise weak market after the company announced the fund raising plan by upto Rs 945 crore by issuing shares to Singapore's state investment arm Temasek.
“The board has decided to raise funds by way of issue of up to 10.80 million equity shares for cash to Aranda Investments (Mauritius) Pte. Ltd. and a wholly owned indirect subsidiary of Temasek Holdings (Pvt) Ltd on preferential basis at price of Rs 875 per equity share aggregating to approximately Rs 945 crore, subject to the requisite approvals of the shareholders,” Glenmark Pharmaceuticals said in a statement.
The stock opened at Rs 905 and touched a high of Rs 909 on the NSE. A combined 1.29 million shares changed hands on the counter till 1141 hours on the NSE and BSE.
“The board has decided to raise funds by way of issue of up to 10.80 million equity shares for cash to Aranda Investments (Mauritius) Pte. Ltd. and a wholly owned indirect subsidiary of Temasek Holdings (Pvt) Ltd on preferential basis at price of Rs 875 per equity share aggregating to approximately Rs 945 crore, subject to the requisite approvals of the shareholders,” Glenmark Pharmaceuticals said in a statement.
The stock opened at Rs 905 and touched a high of Rs 909 on the NSE. A combined 1.29 million shares changed hands on the counter till 1141 hours on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%